ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BCG Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-18D691
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global BCG Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global BCG Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-18D691
Report
June 2025
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
China National Biotec
Serum Institute of India
Japan
Japan BCG Lab
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen

BCG Vaccine Market Size

In 2024, the global market size of BCG Vaccine was estimated to be worth US$ 80.4 million and is forecast to reach approximately US$ 99 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

BCG Vaccine Market

BCG Vaccine Market

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Market Drivers for BCG Vaccine:
High Prevalence of Tuberculosis (TB): The increasing incidence of TB, especially in densely populated and low-income countries, drives the demand for BCG vaccines to prevent the disease, particularly among children and healthcare workers.
Rising Awareness and Immunization Programs: Many governments and health organizations promote vaccination to control TB outbreaks, providing funding and infrastructure to distribute BCG vaccines widely, particularly in high-risk regions.
Growing Healthcare Investments in Emerging Markets: Expanding healthcare infrastructure and government spending in emerging economies have increased the availability and accessibility of the BCG vaccine.
Development of New TB Strains: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has highlighted the need for effective preventative measures like the BCG vaccine.
Market Challenges for BCG Vaccine:
Limited Efficacy in Adults: The BCG vaccine’s effectiveness diminishes in adults, as it primarily prevents severe forms of TB in children rather than pulmonary TB, which is common in adults.
Side Effects and Safety Concerns: For individuals with weakened immune systems, the live BCG vaccine may pose health risks, which restricts its use among certain populations.
Supply Chain Constraints: Manufacturing challenges and periodic shortages impact the availability of BCG vaccines in some regions, particularly low-income countries.
Competition from New Vaccines and Treatments: Research on new TB vaccines and alternative treatments could reduce the reliance on BCG, especially if future solutions offer broader protection across age groups.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine.
The BCG Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCG Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of BCG Vaccine Market Report

Report Metric Details
Report Name BCG Vaccine Market
Forecasted market size in 2031 approximately US$ 99 million
CAGR 3.1%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Self-Procurement
  • UNICEF
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of BCG Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BCG Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the BCG Vaccine Market size in 2031?

Ans: The BCG Vaccine Market size in 2031 will be approximately US$ 99 million.

Who are the main players in the BCG Vaccine Market report?

Ans: The main players in the BCG Vaccine Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC – Institute of Vaccines and Medical Biologicals, Queen Saovabha Mem. Inst, Microgen

What are the Application segmentation covered in the BCG Vaccine Market report?

Ans: The Applications covered in the BCG Vaccine Market report are Self-Procurement, UNICEF, Other

What are the Type segmentation covered in the BCG Vaccine Market report?

Ans: The Types covered in the BCG Vaccine Market report are Immune Vaccine, Therapy Vaccine

Recommended Reports

Tuberculosis Markets

Vaccine Market Size

Child and Adjuvant Vaccines

1 Study Coverage
1.1 BCG Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global BCG Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global BCG Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global BCG Vaccine Market Size Estimates and Forecasts
2.1.1 Global BCG Vaccine Revenue 2020-2031
2.1.2 Global BCG Vaccine Sales 2020-2031
2.2 BCG Vaccine Market Size by Region: 2024 Versus 2031
2.3 BCG Vaccine Sales by Region (2020-2031)
2.3.1 Global BCG Vaccine Sales by Region: 2020-2025
2.3.2 Global BCG Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global BCG Vaccine Sales Market Share by Region (2020-2031)
2.4 BCG Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global BCG Vaccine Revenue by Region: 2020-2025
2.4.2 Global BCG Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global BCG Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global BCG Vaccine Sales by Type (2020-2031)
3.1.1.1 Global BCG Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global BCG Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global BCG Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global BCG Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global BCG Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 BCG Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global BCG Vaccine Sales by Application (2020-2031)
3.2.1.1 Global BCG Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global BCG Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global BCG Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global BCG Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global BCG Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 BCG Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Immune Vaccine of BCG Vaccine Revenue Market Share by Application
3.3.2 Therapy Vaccine of BCG Vaccine Revenue Market Share by Application
4 Global BCG Vaccine by Manufacturers
4.1 Global Top BCG Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global BCG Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global BCG Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top BCG Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global BCG Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global BCG Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global BCG Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key BCG Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global BCG Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global BCG Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global BCG Vaccine Manufacturing Base Distribution, Product Type
4.5.1 BCG Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into BCG Vaccine Market
4.5.3 Manufacturers BCG Vaccine Product Type and Application
4.5.4 Immune Vaccine Market Sales of BCG Vaccine by Manufacturer
4.5.5 Therapy Vaccine Market Sales of BCG Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck BCG Vaccine Products Offered
5.1.4 Merck BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck BCG Vaccine Sales by Product in 2024
5.1.6 Merck BCG Vaccine Sales by Application in 2024
5.1.7 Merck BCG Vaccine Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Japan BCG Lab
5.2.1 Japan BCG Lab Company Information
5.2.2 Japan BCG Lab Description, Business Overview
5.2.3 Japan BCG Lab BCG Vaccine Products Offered
5.2.4 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Japan BCG Lab BCG Vaccine Sales by Product in 2024
5.2.6 Japan BCG Lab BCG Vaccine Sales by Application in 2024
5.2.7 Japan BCG Lab BCG Vaccine Sales by Geographic Area in 2024
5.2.8 Japan BCG Lab Recent Developments
5.3 Serum Institute of India
5.3.1 Serum Institute of India Company Information
5.3.2 Serum Institute of India Description, Business Overview
5.3.3 Serum Institute of India BCG Vaccine Products Offered
5.3.4 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Serum Institute of India BCG Vaccine Sales by Product in 2024
5.3.6 Serum Institute of India BCG Vaccine Sales by Application in 2024
5.3.7 Serum Institute of India BCG Vaccine Sales by Geographic Area in 2024
5.3.8 Serum Institute of India Recent Developments
5.4 AJ Vaccines
5.4.1 AJ Vaccines Company Information
5.4.2 AJ Vaccines Description, Business Overview
5.4.3 AJ Vaccines BCG Vaccine Products Offered
5.4.4 AJ Vaccines BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AJ Vaccines BCG Vaccine Sales by Product in 2024
5.4.6 AJ Vaccines BCG Vaccine Sales by Application in 2024
5.4.7 AJ Vaccines BCG Vaccine Sales by Geographic Area in 2024
5.4.8 AJ Vaccines Recent Developments
5.5 BioFarma
5.5.1 BioFarma Company Information
5.5.2 BioFarma Description, Business Overview
5.5.3 BioFarma BCG Vaccine Products Offered
5.5.4 BioFarma BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 BioFarma BCG Vaccine Sales by Product in 2024
5.5.6 BioFarma BCG Vaccine Sales by Application in 2024
5.5.7 BioFarma BCG Vaccine Sales by Geographic Area in 2024
5.5.8 BioFarma Recent Developments
5.6 GreenSignal Bio Pharma
5.6.1 GreenSignal Bio Pharma Company Information
5.6.2 GreenSignal Bio Pharma Description, Business Overview
5.6.3 GreenSignal Bio Pharma BCG Vaccine Products Offered
5.6.4 GreenSignal Bio Pharma BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 GreenSignal Bio Pharma BCG Vaccine Sales by Product in 2024
5.6.6 GreenSignal Bio Pharma BCG Vaccine Sales by Application in 2024
5.6.7 GreenSignal Bio Pharma BCG Vaccine Sales by Geographic Area in 2024
5.6.8 GreenSignal Bio Pharma Recent Developments
5.7 China National Biotec
5.7.1 China National Biotec Company Information
5.7.2 China National Biotec Description, Business Overview
5.7.3 China National Biotec BCG Vaccine Products Offered
5.7.4 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 China National Biotec BCG Vaccine Sales by Product in 2024
5.7.6 China National Biotec BCG Vaccine Sales by Application in 2024
5.7.7 China National Biotec BCG Vaccine Sales by Geographic Area in 2024
5.7.8 China National Biotec Recent Developments
5.8 Biomed Lublin
5.8.1 Biomed Lublin Company Information
5.8.2 Biomed Lublin Description, Business Overview
5.8.3 Biomed Lublin BCG Vaccine Products Offered
5.8.4 Biomed Lublin BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Biomed Lublin BCG Vaccine Sales by Product in 2024
5.8.6 Biomed Lublin BCG Vaccine Sales by Application in 2024
5.8.7 Biomed Lublin BCG Vaccine Sales by Geographic Area in 2024
5.8.8 Biomed Lublin Recent Developments
5.9 Taj Pharmaceuticals
5.9.1 Taj Pharmaceuticals Company Information
5.9.2 Taj Pharmaceuticals Description, Business Overview
5.9.3 Taj Pharmaceuticals BCG Vaccine Products Offered
5.9.4 Taj Pharmaceuticals BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Taj Pharmaceuticals BCG Vaccine Sales by Product in 2024
5.9.6 Taj Pharmaceuticals BCG Vaccine Sales by Application in 2024
5.9.7 Taj Pharmaceuticals BCG Vaccine Sales by Geographic Area in 2024
5.9.8 Taj Pharmaceuticals Recent Developments
5.10 Ataulpho de Paiva
5.10.1 Ataulpho de Paiva Company Information
5.10.2 Ataulpho de Paiva Description, Business Overview
5.10.3 Ataulpho de Paiva BCG Vaccine Products Offered
5.10.4 Ataulpho de Paiva BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Ataulpho de Paiva BCG Vaccine Sales by Product in 2024
5.10.6 Ataulpho de Paiva BCG Vaccine Sales by Application in 2024
5.10.7 Ataulpho de Paiva BCG Vaccine Sales by Geographic Area in 2024
5.10.8 Ataulpho de Paiva Recent Developments
5.11 IVAC – Institute of Vaccines and Medical Biologicals
5.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
5.11.2 IVAC – Institute of Vaccines and Medical Biologicals Description, Business Overview
5.11.3 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Products Offered
5.11.4 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales by Product in 2024
5.11.6 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales by Application in 2024
5.11.7 IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales by Geographic Area in 2024
5.11.8 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
5.12 Queen Saovabha Mem. Inst
5.12.1 Queen Saovabha Mem. Inst Company Information
5.12.2 Queen Saovabha Mem. Inst Description, Business Overview
5.12.3 Queen Saovabha Mem. Inst BCG Vaccine Products Offered
5.12.4 Queen Saovabha Mem. Inst BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Queen Saovabha Mem. Inst BCG Vaccine Sales by Product in 2024
5.12.6 Queen Saovabha Mem. Inst BCG Vaccine Sales by Application in 2024
5.12.7 Queen Saovabha Mem. Inst BCG Vaccine Sales by Geographic Area in 2024
5.12.8 Queen Saovabha Mem. Inst Recent Developments
5.13 Microgen
5.13.1 Microgen Company Information
5.13.2 Microgen Description, Business Overview
5.13.3 Microgen BCG Vaccine Products Offered
5.13.4 Microgen BCG Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Microgen BCG Vaccine Sales by Product in 2024
5.13.6 Microgen BCG Vaccine Sales by Application in 2024
5.13.7 Microgen BCG Vaccine Sales by Geographic Area in 2024
5.13.8 Microgen Recent Developments
6 North America
6.1 North America BCG Vaccine Market Size YoY Growth 2020-2031
6.2 North America BCG Vaccine Market Facts & Figures by Country
6.2.1 North America BCG Vaccine Sales by Country (2020-2031)
6.2.2 North America BCG Vaccine Revenue by Country (2020-2031)
6.3 North America BCG Vaccine Sales by Type (2020-2025)
6.4 North America BCG Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific BCG Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific BCG Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific BCG Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific BCG Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific BCG Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific BCG Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe BCG Vaccine Market Size YoY Growth 2020-2031
8.2 Europe BCG Vaccine Market Facts & Figures by Country
8.2.1 Europe BCG Vaccine Sales by Country (2020-2031)
8.2.2 Europe BCG Vaccine Revenue by Country (2020-2031)
8.3 Europe BCG Vaccine Sales by Type (2020-2025)
8.4 Europe BCG Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America BCG Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America BCG Vaccine Market Facts & Figures by Country
9.2.1 Latin America BCG Vaccine Sales by Country (2020-2031)
9.2.2 Latin America BCG Vaccine Revenue by Country (2020-2031)
9.3 Latin America BCG Vaccine Sales by Type (2020-2025)
9.4 Latin America BCG Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America BCG Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa BCG Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa BCG Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa BCG Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa BCG Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa BCG Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 BCG Vaccine Supply Chain Analysis
11.2 BCG Vaccine Key Raw Materials and Upstream Suppliers
11.3 BCG Vaccine Clients Analysis
11.4 BCG Vaccine Sales Channel and Sales Model Analysis
11.4.1 BCG Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 BCG Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 BCG Vaccine Distributors
12 BCG Vaccine Market Dynamics
12.1 BCG Vaccine Industry Trends
12.2 BCG Vaccine Market Drivers
12.3 BCG Vaccine Market Challenges
12.4 BCG Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
China National Biotec
Serum Institute of India
Japan
Japan BCG Lab
AJ Vaccines
Biofarma
GreenSignal Bio Pharma
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
List of Tables
 Table 1. Global BCG Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global BCG Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global BCG Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global BCG Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 5. Global BCG Vaccine Sales Forecast by Region (2026-2031) & (K Dose)
 Table 6. Global BCG Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global BCG Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global BCG Vaccine Sales Volume by Type (2020-2025) & (K Dose)
 Table 9. Global BCG Vaccine Sales Volume by Type (2026-2031) & (K Dose)
 Table 10. Global BCG Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global BCG Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global BCG Vaccine Sales Volume by Application (2020-2025) & (K Dose)
 Table 13. Global BCG Vaccine Sales Volume by Application (2026-2031) & (K Dose)
 Table 14. Global BCG Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global BCG Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global BCG Vaccine Sales by Manufacturer (2020-2025) & (K Dose)
 Table 17. Global BCG Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. BCG Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. BCG Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers BCG Vaccine Price (2020-2025) & (US$/Dose)
 Table 21. Ranking of Global Top BCG Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global BCG Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global BCG Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine as of 2024)
 Table 24. BCG Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into BCG Vaccine Market
 Table 26. Manufacturers BCG Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck BCG Vaccine Product
 Table 31. Merck BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of BCG Vaccine by Product in 2024
 Table 33. Merck Sales Proportion of BCG Vaccine by Application in 2024
 Table 34. Merck Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. Japan BCG Lab Company Information
 Table 37. Japan BCG Lab Description and Business Overview
 Table 38. Japan BCG Lab BCG Vaccine Product
 Table 39. Japan BCG Lab BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 40. Japan BCG Lab Sales Proportion of BCG Vaccine by Product in 2024
 Table 41. Japan BCG Lab Sales Proportion of BCG Vaccine by Application in 2024
 Table 42. Japan BCG Lab Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 43. Japan BCG Lab Recent Developments
 Table 44. Serum Institute of India Company Information
 Table 45. Serum Institute of India Description and Business Overview
 Table 46. Serum Institute of India BCG Vaccine Product
 Table 47. Serum Institute of India BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 48. Serum Institute of India Sales Proportion of BCG Vaccine by Product in 2024
 Table 49. Serum Institute of India Sales Proportion of BCG Vaccine by Application in 2024
 Table 50. Serum Institute of India Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 51. Serum Institute of India Recent Developments
 Table 52. AJ Vaccines Company Information
 Table 53. AJ Vaccines Description and Business Overview
 Table 54. AJ Vaccines BCG Vaccine Product
 Table 55. AJ Vaccines BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 56. AJ Vaccines Sales Proportion of BCG Vaccine by Product in 2024
 Table 57. AJ Vaccines Sales Proportion of BCG Vaccine by Application in 2024
 Table 58. AJ Vaccines Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 59. AJ Vaccines Recent Developments
 Table 60. BioFarma Company Information
 Table 61. BioFarma Description and Business Overview
 Table 62. BioFarma BCG Vaccine Product
 Table 63. BioFarma BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 64. BioFarma Sales Proportion of BCG Vaccine by Product in 2024
 Table 65. BioFarma Sales Proportion of BCG Vaccine by Application in 2024
 Table 66. BioFarma Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 67. BioFarma Recent Developments
 Table 68. GreenSignal Bio Pharma Company Information
 Table 69. GreenSignal Bio Pharma Description and Business Overview
 Table 70. GreenSignal Bio Pharma BCG Vaccine Product
 Table 71. GreenSignal Bio Pharma BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. GreenSignal Bio Pharma Sales Proportion of BCG Vaccine by Product in 2024
 Table 73. GreenSignal Bio Pharma Sales Proportion of BCG Vaccine by Application in 2024
 Table 74. GreenSignal Bio Pharma Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 75. GreenSignal Bio Pharma Recent Developments
 Table 76. China National Biotec Company Information
 Table 77. China National Biotec Description and Business Overview
 Table 78. China National Biotec BCG Vaccine Product
 Table 79. China National Biotec BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 80. China National Biotec Sales Proportion of BCG Vaccine by Product in 2024
 Table 81. China National Biotec Sales Proportion of BCG Vaccine by Application in 2024
 Table 82. China National Biotec Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 83. China National Biotec Recent Developments
 Table 84. Biomed Lublin Company Information
 Table 85. Biomed Lublin Description and Business Overview
 Table 86. Biomed Lublin BCG Vaccine Product
 Table 87. Biomed Lublin BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Biomed Lublin Sales Proportion of BCG Vaccine by Product in 2024
 Table 89. Biomed Lublin Sales Proportion of BCG Vaccine by Application in 2024
 Table 90. Biomed Lublin Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 91. Biomed Lublin Recent Developments
 Table 92. Taj Pharmaceuticals Company Information
 Table 93. Taj Pharmaceuticals Description and Business Overview
 Table 94. Taj Pharmaceuticals BCG Vaccine Product
 Table 95. Taj Pharmaceuticals BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 96. Taj Pharmaceuticals Sales Proportion of BCG Vaccine by Product in 2024
 Table 97. Taj Pharmaceuticals Sales Proportion of BCG Vaccine by Application in 2024
 Table 98. Taj Pharmaceuticals Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 99. Taj Pharmaceuticals Recent Developments
 Table 100. Ataulpho de Paiva Company Information
 Table 101. Ataulpho de Paiva Description and Business Overview
 Table 102. Ataulpho de Paiva BCG Vaccine Product
 Table 103. Ataulpho de Paiva BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Ataulpho de Paiva Sales Proportion of BCG Vaccine by Product in 2024
 Table 105. Ataulpho de Paiva Sales Proportion of BCG Vaccine by Application in 2024
 Table 106. Ataulpho de Paiva Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 107. Ataulpho de Paiva Recent Developments
 Table 108. IVAC – Institute of Vaccines and Medical Biologicals Company Information
 Table 109. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
 Table 110. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Product
 Table 111. IVAC – Institute of Vaccines and Medical Biologicals BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 112. IVAC – Institute of Vaccines and Medical Biologicals Sales Proportion of BCG Vaccine by Product in 2024
 Table 113. IVAC – Institute of Vaccines and Medical Biologicals Sales Proportion of BCG Vaccine by Application in 2024
 Table 114. IVAC – Institute of Vaccines and Medical Biologicals Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 115. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
 Table 116. Queen Saovabha Mem. Inst Company Information
 Table 117. Queen Saovabha Mem. Inst Description and Business Overview
 Table 118. Queen Saovabha Mem. Inst BCG Vaccine Product
 Table 119. Queen Saovabha Mem. Inst BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 120. Queen Saovabha Mem. Inst Sales Proportion of BCG Vaccine by Product in 2024
 Table 121. Queen Saovabha Mem. Inst Sales Proportion of BCG Vaccine by Application in 2024
 Table 122. Queen Saovabha Mem. Inst Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 123. Queen Saovabha Mem. Inst Recent Developments
 Table 124. Microgen Company Information
 Table 125. Microgen Description and Business Overview
 Table 126. Microgen BCG Vaccine Product
 Table 127. Microgen BCG Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Microgen Sales Proportion of BCG Vaccine by Product in 2024
 Table 129. Microgen Sales Proportion of BCG Vaccine by Application in 2024
 Table 130. Microgen Sales Proportion of BCG Vaccine by Geographic Area in 2024
 Table 131. Microgen Recent Developments
 Table 132. North America BCG Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 133. North America BCG Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 134. North America BCG Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 135. North America BCG Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 136. North America BCG Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 137. North America BCG Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 138. Asia-Pacific BCG Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 139. Asia-Pacific BCG Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 140. Asia-Pacific BCG Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 141. Asia-Pacific BCG Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 142. Asia-Pacific BCG Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 143. Asia-Pacific BCG Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 144. Europe BCG Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 145. Europe BCG Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 146. Europe BCG Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 147. Europe BCG Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 148. Europe BCG Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 149. Europe BCG Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 150. Latin America BCG Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 151. Latin America BCG Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 152. Latin America BCG Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 153. Latin America BCG Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 154. Latin America BCG Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 155. Latin America BCG Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 156. Middle East and Africa BCG Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 157. Middle East and Africa BCG Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 158. Middle East and Africa BCG Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 159. Middle East and Africa BCG Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 160. Middle East and Africa BCG Vaccine Sales by Type (2020-2025) & (K Dose)
 Table 161. Middle East and Africa BCG Vaccine Sales by Application (2020-2025) & (K Dose)
 Table 162. BCG Vaccine Key Raw Materials, Industry Status and Trend
 Table 163. BCG Vaccine Key Raw Materials and Upstream Suppliers
 Table 164. BCG Vaccine Clients Status and Trend
 Table 165. BCG Vaccine Typical Clients
 Table 166. BCG Vaccine Distributors
 Table 167. BCG Vaccine Market Trends
 Table 168. BCG Vaccine Market Drivers
 Table 169. BCG Vaccine Market Challenges
 Table 170. BCG Vaccine Market Restraints
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. BCG Vaccine Product Picture
 Figure 2. Global BCG Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global BCG Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Immune Vaccine Product Picture
 Figure 5. Therapy Vaccine Product Picture
 Figure 6. Global BCG Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global BCG Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 8. Self-Procurement
 Figure 9. UNICEF
 Figure 10. Other
 Figure 11. BCG Vaccine Report Years Considered
 Figure 12. Global BCG Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global BCG Vaccine Market Size 2020-2031 (US$ Million)
 Figure 14. Global BCG Vaccine Sales 2020-2031 (K Dose)
 Figure 15. Global BCG Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global BCG Vaccine Revenue Market Share by Region (2020-2031)
 Figure 17. Global BCG Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global BCG Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. BCG Vaccine Average Selling Price (ASP) by Type (2020-2025) & (US$/Dose)
 Figure 20. Global BCG Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global BCG Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. BCG Vaccine Average Selling Price (ASP) by Application (2020-2025) & (US$/Dose)
 Figure 23. Immune Vaccine of BCG Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Therapy Vaccine of BCG Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global BCG Vaccine Sales Share by Manufacturer in 2024
 Figure 26. BCG Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Immune Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 28. Therapy Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America BCG Vaccine Revenue 2020-2031 (US$ Million)
 Figure 30. North America BCG Vaccine Sales Market Share by Type (2020-2025)
 Figure 31. North America BCG Vaccine Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific BCG Vaccine Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific BCG Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific BCG Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific BCG Vaccine Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific BCG Vaccine Sales Market Share by Application (2020-2025)
 Figure 37. Europe BCG Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe BCG Vaccine Sales Market Share by Country (2020-2031)
 Figure 39. Europe BCG Vaccine Revenue Market Share by Country (2020-2031)
 Figure 40. Europe BCG Vaccine Sales Market Share by Type (2020-2025)
 Figure 41. Europe BCG Vaccine Sales Market Share by Application (2020-2025)
 Figure 42. Latin America BCG Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America BCG Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America BCG Vaccine Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America BCG Vaccine Sales Market Share by Type (2020-2025)
 Figure 46. Latin America BCG Vaccine Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa BCG Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa BCG Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa BCG Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa BCG Vaccine Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa BCG Vaccine Sales Market Share by Application (2020-2025)
 Figure 52. BCG Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of BCG Vaccine Raw Materials by Region in 2024
 Figure 54. BCG Vaccine Distribution Channels
 Figure 55. Global BCG Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global BCG Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global BCG Vaccination Market Research Report 2025
Global BCG and Tuberculosis Vaccine Market Research Report 2025
Global Tuberculosis Vaccination Market Research Report 2025
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global TB Disease Vaccine Market Research Report 2025
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Global Tuberculosis Vaccines Market Research Report 2024
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Global BCG Vaccine for Intradermal Injection Market Research Report 2024
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Brucellosis Vaccines Market Research Report 2025
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions